Thrombocytopenia and Coronary Artery Disease, the Existing Dilemmas

1. Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention, 2011 ACCF/AHA guideline for coronary artery bypass graft surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation. 2016;134:e123-e155. doi: 10.1161/CIR.0000000000000404.10.1161/CIR.000000000000040427026020Open DOISearch in Google Scholar

2. Ibanez B, James S, Agewall S, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119-177. doi: 10.1093/eurheartj/ehx393.10.1093/eurheartj/ehx39328886621Open DOISearch in Google Scholar

3. Bhatt DL, Hulot JS, Moliterno DJ, Harrington RA. Antiplatelet and anticoagulation therapy for acute coronary syndromes. Circ Res. 2014;114:1929-1943. doi: 10.1161/CIRCRESAHA.114.302737.10.1161/CIRCRESAHA.114.30273724902976Open DOISearch in Google Scholar

4. Udell JA, Bonaca MP, Collet JP, et al. Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: A collaborative meta-analysis of randomized trials. Eur Heart J. 2016;37:390-399. doi: 10.1093/eurheartj/ehv443.10.1093/eurheartj/ehv44326324537Open DOISearch in Google Scholar

5. McClure MW, Berkowitz SD, Sparapani R, et al. Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT) trial experience. Circulation. 1999;99:2892-2900. doi: 10.1161/01.cir.99.22.2892.10.1161/01.cir.99.22.289210359733Open DOISearch in Google Scholar

6. Cameron HA, Phillips R, Ibbotson RM, Carson PH. Platelet size in myocardial infarction. Br Med J (Clin Res Ed). 1983;287:449-451. doi: 10.1136/bmj.287.6390.449.10.1136/bmj.287.6390.44915487026411169Open DOISearch in Google Scholar

7. O'Malley T, Langhorne P, Elton RA, Stewart C. Platelet size in stroke patients. Stroke. 1995;26:995-999.10.1161/01.STR.26.6.9957762052Search in Google Scholar

8. Asher E, Fefer P, Shechter M, et al. Increased mean platelet volume is associated with non-responsiveness to clopidogrel. Thromb Haemost. 2014;112:137-141. doi: 10.1160/TH13-10-0845.10.1160/TH13-10-084524696016Search in Google Scholar

9. VanWijk Michiel, VanBavel Ed, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res. 2003;59:277-287. doi: 10.1186/1471-2121-14-23.10.1186/1471-2121-14-23365141423607880Open DOISearch in Google Scholar

10. Jy W, Horstman LL, Arce M, Ahn YS. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med. 1992;119:334-345.Search in Google Scholar

11. Ozner MD, Ahn YS, Horstman LL, Jy W, Kolodny L, Myerberg RJ. Chronic platelet activation and acute coronary syndromes in 13 middle-aged patients. Clin Appl Thromb Hemost. 1997;3:46-53.10.1177/107602969700300107Search in Google Scholar

12. Jachmann-Jahn U, Cornely OA, Laufs U, et al. Acute anterior myocardial infarction as first manifestation of acute myeloid leukemia. Ann Hematol. 2001;80:677-681.10.1007/s00277010035311757728Search in Google Scholar

13. Shah AH, Anderson RA, Khan AR, Kinnaird TD. Management of immune thrombocytic purpura and acute coronary syndrome: A double-edged sword! Hellenic J Cardiol. 2016;pii:S1109-9666(16)30151-8. doi: 10.1016/j.hjc.2014.10.001.10.1016/j.hjc.2014.10.00127639318Search in Google Scholar

14. Kohl BA. Con: Should aspirin be continued after cardiac surgery in the setting of thrombocytopenia? J Cardiothorac Vasc Anesth. 2006;20:114-116. doi: 10.1053/j.jvca.2005.10.007.10.1053/j.jvca.2005.10.00716458230Open DOISearch in Google Scholar

15. McCarthy CP, Steg G, Bhatt DL. The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: a clinical conundrum. Eur Heart J. 2017;38:3488-3492. doi: 10.1093/eurheartj/ehx531.10.1093/eurheartj/ehx531583766129020292Open DOISearch in Google Scholar

16. Wang TY, Ou FS, Roe MT, et al. Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice. Circulation. 2009;119:2454-2462. doi: 10.1161/CIRCULATIONAHA.108.827162.10.1161/CIRCULATIONAHA.108.82716219398666Open DOISearch in Google Scholar

17. Yadav M, Généreux P, Giustino G, et al. Effect of baseline thrombocytopenia on ischemic outcomes in patients with acute coronary syndromes who undergo percutaneous coronary intervention. Can J Cardiol. 2016;32:226-233. doi: 10.1016/j.cjca.2015.05.020.10.1016/j.cjca.2015.05.02026341303Open DOISearch in Google Scholar

18. McClure MW, Berkowitz SD, Sparapani R, et al. Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT) trial experience. Circulation. 1999;99:2892-2900. doi: 10.1161/01.cir.99.22.2892.10.1161/01.cir.99.22.289210359733Open DOISearch in Google Scholar

19. Warkentin TE, Crowther MA. Adverse prognostic significance of thrombocytopenia in acute coronary syndrome. Can anything be done about it? Circulation. 2009;119:2420-2422. doi: 10.1161/CIRCULATIONAHA.109.858316.10.1161/CIRCULATIONAHA.109.85831619433766Open DOISearch in Google Scholar

20. Yusuf SW, Iliescu C, Bathina JD, Daher IN, Durand JB. Antiplatelet Therapy and Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome and Thrombocytopenia. Tex Heart Inst J. 2010;37:336-340.Search in Google Scholar

21. Schwartz RS. Immune thrombocytopenic purpura – from agony to agonist. N Engl J Med. 2007;357:2299-2301. doi: 10.1056/NEJMe0707126.10.1056/NEJMe070712618046034Open DOISearch in Google Scholar